1265-VDAC2 Pan-Cancer Analysis: Decoding Tumor Evolution

The paper details a comprehensive multi-omics and pan-cancer study investigating the role of VDAC2, a mitochondrial protein, in tumor development and immune system evasion. Researchers utilized machine learning, spatial transcriptomics, and laboratory experiments to demonstrate that VDAC2 is significantly overexpressed in most solid tumors, where it promotes cell proliferation, metabolic shifts, and resistance to cell death. Crucially, the study identifies a specific VDAC2-BAK1-IFNγ signaling pathway that facilitates an immunosuppressive environment by hindering the ability of CD8+ T cells to eliminate cancer cells. Findings suggest that high levels of this protein correlate with poor patient prognosis and resistance to certain therapies, particularly in digestive cancers like gastric cancer. Ultimately, the authors propose VDAC2 as a versatile diagnostic biomarker and a promising target for novel cancer immunotherapies.References:Yan J, Wang J, Dong H, et al. Perspectives from machine learning and multi-omics to decoding the effects of VDAC2 malignant subsets on tumor evolution[J]. npj Precision Oncology, 2026.前往小宇宙评论区与主播互动